Literature DB >> 2798704

Disclosure of traumas and health among Holocaust survivors.

J W Pennebaker1, S D Barger, J Tiebout.   

Abstract

On the basis of a theory of inhibition and psychosomatics, it was predicted that the more individuals disclosed personally traumatic experiences, the better their long-term health following the disclosure. Thirty-three Holocaust survivors talked for 1-2 hours about their personal experiences during World War II while skin conductance level (SCL) and heart rate (HR) were continuously monitored. Each videotaped interview was rated by independent judges once every minute on the degree to which the survivor's experience was traumatic. For each subject, the trauma ratings were correlated with minute-by-minute SCL and HR readings. Based on previous research, negative trauma-SCL correlations are indicative of high personal disclosure, whereas positive trauma-SCL correlations suggest low disclosure, whereas positive trauma-SCL correlations suggest low disclosure. Approximately 14 months after the interview, self-reports of the subjects' health were collected. Controlling for pre-interview health problems, degree of disclosure during the interview was found to be positively correlated with long-term health after the interview. The possible health benefits of disclosure are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2798704     DOI: 10.1097/00006842-198909000-00009

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  19 in total

1.  Going home: giving voice to memory strategies of young Mayan refugees who returned to Guatemala as a community.

Authors:  C Rousseau; M Morales; P Foxen
Journal:  Cult Med Psychiatry       Date:  2001-06

Review 2.  Self-disclosure of serostatus by youth who are HIV-positive: a review.

Authors:  Candace A Thoth; Christy Tucker; Matthew Leahy; Sunita M Stewart
Journal:  J Behav Med       Date:  2013-01-01

3.  Facing the Language-Memory Problem in the Study of Autobiographical Memory.

Authors:  Eleonora Bartoli; Andrea Smorti
Journal:  Integr Psychol Behav Sci       Date:  2019-09

4.  Raychelle Cassada Lohmann: The Anger Workbook for Teens (Second Edition) : Oakland, CA: Instant Help Books, 2019, 184 pp, ISBN: 978-1-68403-245-7.

Authors:  Chris Fradkin
Journal:  J Youth Adolesc       Date:  2019-08-24

5.  The Japanese American wartime incarceration: Examining the scope of racial trauma.

Authors:  Donna K Nagata; Jacqueline H J Kim; Kaidi Wu
Journal:  Am Psychol       Date:  2019-01

6.  Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care.

Authors:  A F Schilte; P J Portegijs; A H Blankenstein; H E van Der Horst; M B Latour; J T van Eijk; J A Knottnerus
Journal:  BMJ       Date:  2001-07-14

7.  Development of a post-intensive care unit storytelling intervention for surrogates involved in decisions to limit life-sustaining treatment.

Authors:  Yael Schenker; Mary Amanda Dew; Charles F Reynolds; Robert M Arnold; Greer A Tiver; Amber E Barnato
Journal:  Palliat Support Care       Date:  2014-02-13

8.  Gender-specific effects of an augmented written emotional disclosure intervention on posttraumatic, depressive, and HIV-disease-related outcomes: a randomized, controlled trial.

Authors:  Gail Ironson; Conall O'Cleirigh; Jane Leserman; Rick Stuetzle; Joanne Fordiani; MaryAnn Fletcher; Neil Schneiderman
Journal:  J Consult Clin Psychol       Date:  2012-12-17

Review 9.  Emotional disclosure interventions for chronic pain: from the laboratory to the clinic.

Authors:  Mark A Lumley; Elyse R Sklar; Jennifer N Carty
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

10.  Storytelling in the Early Bereavement Period to Reduce Emotional Distress Among Surrogates Involved in a Decision to Limit Life Support in the ICU: A Pilot Feasibility Trial.

Authors:  Amber E Barnato; Yael Schenker; Greer Tiver; Mary Amanda Dew; Robert M Arnold; Eduardo R Nunez; Charles F Reynolds
Journal:  Crit Care Med       Date:  2017-01       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.